Medicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase
ChemMedChem · 2026
DOI: 10.1002/cmdc.70494 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2026. Verfasst von José Arion da Silva Moura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Research in Therapeutic Innovation Suely Galdino (NUPIT SG), Biosciences Center, Universidade Federal de Pernambuco (UFPE), Recife, Pernamb…. Hauptthemen laut MEDLINE: HIV Reverse Transcriptase, Reverse Transcriptase Inhibitors, Drug Design, Thiazoles. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco, Conseil National de la Recherche Scientifique.
Abstract (Originalsprache)
The therapy to treat the Human Immunodeficiency virus (HIV) and decrease the viral load has been a challenge since its discovery due to its ability to mutate, escape from drug therapies, and immunologic system. Consequently, the development of new therapies, especially potential molecules that focus on specific viral mechanisms to block viral replication, became a critical challenge in recent decades. The Reverse Transcriptase (RT) is an RNA‐ and DNA‐dependent DNA polymerase enzyme that is responsible for transcribing viral RNA into double‐stranded DNA. Non‐nucleoside RT Inhibitors perform important role in HIV therapy, and they are responsible for inhibiting RT by blocking its allosteric site, which shows physico‐chemical properties such as high hydrophobicity and key amino acid‐to‐hydrogen bond interactions. For this reason, designing new molecules with innovative heterocycles compatible with these characteristics can provide new potential inhibitors. For example, pentacyclic heterocycles like thiazole and its derivatives like thiazolidinedione, which have physico‐chemical properties that can interact with the allosteric site of RT, can be a new perspective in designing new Non‐nucleoside RT Inhibitors. This work reviews the scientific literature concerning these compounds and can help the design of new antiviral therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Research in Therapeutic Innovation Suely Galdino (NUPIT SG), Biosciences Center, Universidade Federal de Pernambuco (UFPE), Recife, Pernambuco, Brazil.
- UMR 5234, Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, CNRS, Bordeaux, France.
ORCID-Profile: Thaynara Paula Warren Bezerra, Patricia Recordon-Pinson, Michelly Cristiny Pereira, Marie-Line Andreola
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
- Conseil National de la Recherche Scientifique
Zitieren
APA
da Silva Moura, J. A., de Melo, M. V. G., do Nascimento, D. R. S., Bezerra, T. P. W., Métifiot, M., Recordon-Pinson, P., da Rocha Pitta, M. G., da Rocha Pitta, M. G., Pereira, M. C., & Andreola, M. L. (2026). Medicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase. ChemMedChem. https://doi.org/10.1002/cmdc.70494
Vancouver
da Silva Moura JA, de Melo MVG, do Nascimento DRS, Bezerra TPW, Métifiot M, Recordon-Pinson P, et al. Medicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase. ChemMedChem. 2026. doi:10.1002/cmdc.70494
BibTeX
@article{daSilvaMoura2026,
author = {da Silva Moura, José Arion and de Melo, Matheus Vinicius Guimarães and do Nascimento, Diane Regis Santos and Bezerra, Thaynara Paula Warren and Métifiot, Mathieu and Recordon-Pinson, Patricia and da Rocha Pitta, Maira Galdino and da Rocha Pitta, Marina Galdino and Pereira, Michelly Cristiny and Andreola, Marie-Line},
title = {Medicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70494}
}
EUVIMED